121 related articles for article (PubMed ID: 9164508)
1. The regrowth of rectal adenocarcinoma after pre-operative radiotherapy with a report of two cases.
Kotera H; Kusunoki M; Yanagi H; Yamamura T; Utsunomiya J
Hepatogastroenterology; 1997; 44(14):394-7. PubMed ID: 9164508
[TBL] [Abstract][Full Text] [Related]
2. Treatment of T1-T2 rectal tumors by contact therapy and interstitial brachytherapy.
Coatmeur O; Truc G; Barillot I; Horiot JC; Maingon P
Radiother Oncol; 2004 Feb; 70(2):177-82. PubMed ID: 15028405
[TBL] [Abstract][Full Text] [Related]
3. Prognostic and predictive factors after surgical treatment for locally recurrent rectal cancer: a single institute experience.
Asoglu O; Karanlik H; Muslumanoglu M; Igci A; Emek E; Ozmen V; Kecer M; Parlak M; Kapran Y
Eur J Surg Oncol; 2007 Dec; 33(10):1199-206. PubMed ID: 17400423
[TBL] [Abstract][Full Text] [Related]
4. Influence of p53 status on prognosis in preoperatively irradiated rectal carcinoma.
Nehls O; Klump B; Holzmann K; Lammering G; Borchard F; Gruenagel HH; Gaco V; Gregor M; Porschen R
Cancer; 1999 Jun; 85(12):2541-8. PubMed ID: 10375100
[TBL] [Abstract][Full Text] [Related]
5. Importance of tumor regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapy.
Bouzourene H; Bosman FT; Seelentag W; Matter M; Coucke P
Cancer; 2002 Feb; 94(4):1121-30. PubMed ID: 11920483
[TBL] [Abstract][Full Text] [Related]
6. Effect of adjuvant radiotherapy on local recurrence in stage II rectal cancer.
Park IJ; Kim HC; Yu CS; Kim TW; Jang SJ; Kim JC
Ann Surg Oncol; 2008 Feb; 15(2):519-25. PubMed ID: 17960464
[TBL] [Abstract][Full Text] [Related]
7. p53 immunohistochemical staining predicts residual disease after chemoradiation in patients with high-risk rectal cancer.
Spitz FR; Giacco GG; Hess K; Larry L; Rich TA; Janjan N; Cleary KR; Skibber JM
Clin Cancer Res; 1997 Oct; 3(10):1685-90. PubMed ID: 9815551
[TBL] [Abstract][Full Text] [Related]
8. Short versus conventional preoperative radiotherapy of rectal cancer: indications.
Klenova A; Georgiev R; Kurtev P; Kurteva G
J BUON; 2007; 12(2):227-32. PubMed ID: 17600877
[TBL] [Abstract][Full Text] [Related]
9. Prognostic values of radiation-induced p53 in adjacent normal mucosa and p21WAF1/CIP1 expression in rectal cancer patients.
Yoshikawa R; Yanagi H; Kusunoki M; Fujiwara Y; Noda M; Hashimoto-Tamaoki T; Yamamura T
Int J Oncol; 2002 Dec; 21(6):1223-8. PubMed ID: 12429971
[TBL] [Abstract][Full Text] [Related]
10. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
11. Recurrent rectal carcinoma treated with high dose rate intraluminal brachytherapy.
Begum N; Asghar AH; Shahida N; Jawad AG; Sher MK; Ayub K
J Coll Physicians Surg Pak; 2003 Sep; 13(9):528-9. PubMed ID: 12971877
[TBL] [Abstract][Full Text] [Related]
12. Pre-operative radiotherapy in rectal cancer: evaluation of irradiation effects on cellular undifferentiation and its influence on prognosis.
Reis Neto JA; Quilici FA; Cordeiro F; Ciquini S; Reis JA
Hepatogastroenterology; 1999; 46(29):2825-30. PubMed ID: 10576354
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors for disease-free survival in patients with T3-4 or N+ rectal cancer treated with preoperative chemoradiation therapy, surgery, and intraoperative irradiation.
Díaz-González JA; Calvo FA; Cortés J; García-Sabrido JL; Gómez-Espí M; Del Valle E; Muñoz-Jiménez F; Alvarez E
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1122-8. PubMed ID: 16406393
[TBL] [Abstract][Full Text] [Related]
14. [A case of local recurrence of rectal cancer that achieved a complete response with high-dose interstitial brachytherapy].
Sekimoto M; Monden T; Tomita N; Nose T; Tanaka E; Amano M; Nakamura H; Monden M
Gan To Kagaku Ryoho; 1997 Sep; 24(12):1848-50. PubMed ID: 9382548
[TBL] [Abstract][Full Text] [Related]
15. Alteration of DNA ploidy status and cell proliferation induced by preoperative radiotherapy is a prognostic factor in rectal cancer.
Lammering G; Taher MM; Gruenagel HH; Borchard F; Porschen R
Clin Cancer Res; 2000 Aug; 6(8):3215-21. PubMed ID: 10955806
[TBL] [Abstract][Full Text] [Related]
16. Morphological changes in tumour type after radiotherapy are accompanied by changes in gene expression profile but not in clinical behaviour.
Nagtegaal I; Gaspar C; Marijnen C; Van De Velde C; Fodde R; Van Krieken H
J Pathol; 2004 Oct; 204(2):183-92. PubMed ID: 15378567
[TBL] [Abstract][Full Text] [Related]
17. Biological effects of preoperative radiotherapy on metastatic lymph nodes from rectal cancer.
Ibi I; Saito Y; Agnifili A; De Bernardinis G; Citone G; Muto T
Am Surg; 1999 May; 65(5):427-30. PubMed ID: 10231210
[TBL] [Abstract][Full Text] [Related]
18. [Preoperative radiotherapy of rectal cancer. The Lyons experience, 1985-1996. Prognostic study apropos of 312 patients].
Gérard JP; Chapet O; Morignat E; Romestaing P; Mornex F; Acharki A
Ann Chir; 1999; 53(10):1003-10. PubMed ID: 10670149
[TBL] [Abstract][Full Text] [Related]
19. Local control after the use of adjuvant electron beam intraoperative radiotherapy in patients with high-risk head and neck cancer: the UCSF experience.
Ling SM; Roach M; Fu KK; Coleman C; Chan A; Singer M
Cancer J Sci Am; 1996; 2(6):321-9. PubMed ID: 9166552
[TBL] [Abstract][Full Text] [Related]
20. [Local tumor control and (disease-free) survival after surgery with pre- and intraoperative radiotherapy for primary non-resectable rectal carcinoma and local recurrence].
Mannaerts GH; Martijn H; Rutten HJ; Hanssens PE; Wiggers T
Ned Tijdschr Geneeskd; 2001 Jul; 145(30):1460-6. PubMed ID: 11503316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
